Didier Laurens

About Didier Laurens

Didier Laurens is a French executive in the healthcare and financial sectors, best known today as Chief Executive Officer and board member of Advicenne, a biopharmaceutical company listed on Euronext Paris. He joined Advicenne in May 2021 as Chief Executive Officer and later also assumed the role of Chief Financial Officer, a combination that highlights a rare profile blending corporate governance, strategic execution, and financial leadership. At Advicenne, he sits at the center of the company’s efforts to develop and commercialize treatments for rare kidney diseases, with a clear focus on industrial execution, regulatory progress, and shareholder value creation. Before joining Advicenne, Didier Laurens held several senior roles in corporate finance and healthcare. He was Chief Financial Officer at eCential Robotics, a private medical technology company focused on spinal surgery solutions. He also served as Chief Financial Officer at Pixium Vision, a listed medtech company, and as interim CFO at Korian, after previously being Director of Financing, Treasury and Investor Relations there. This background shows deep expertise in financing growth, capital markets, treasury management, investor communication, and the financial structuring of healthcare businesses. Academically, Didier Laurens brings a strong scientific foundation to his financial career. He holds a doctorate in pharmacy and completed postgraduate training in galenic pharmacy, alongside a certification from the French Society of Financial Analysts (CIIA / SFAF). This combination of pharmaceutical and financial expertise is particularly valuable in biotech, where executive decisions must balance clinical development, regulatory requirements, and economic performance. Earlier in his career, he spent many years as a financial analyst specializing in healthcare at Oddo BHF and Société Générale, where he also led mid-cap equity research and took part in numerous healthcare IPOs. At Advicenne, Didier Laurens is associated with a leadership style centered on execution, financial discipline, and credibility with the investment community. His role has involved guiding the company through commercial development, supporting the rollout of its products, and reinforcing the operational and financial milestones needed in a sector where cash management, market access, and regulatory progress are critical to long-term success.